Hilgeroth A - Search Results

1

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis.

Lentz F, Reiling N, Martins A, Molnár J, Hilgeroth A. Lentz F, et al. Among authors: hilgeroth a. Molecules. 2018 Apr 4;23(4):825. doi: 10.3390/molecules23040825. Molecules. 2018. PMID: 29617279 Free PMC article.

2

The interaction between resistance modifiers such as pyrido[3,2-g]quinoline, aza-oxafluorene and pregnane derivatives with DNA, plasmid DNA and tRNA.

Sharples D, Spengler G, Molnár J, Antal Z, Molnár A, Kiss JT, Szabó JA, Hilgeroth A, Gallo S, Mahamoud A, Barbe J. Sharples D, et al. Among authors: hilgeroth a. Eur J Med Chem. 2005 Feb;40(2):195-202. doi: 10.1016/j.ejmech.2004.10.011. Eur J Med Chem. 2005. PMID: 15694654

3

Physicochemical characteristics of novel P-glycoprotein inhibitors of the cage dimeric 1,4-dihydropyridine type.

Wollmann J, Molnár J, Hilgeroth A. Wollmann J, et al. Among authors: hilgeroth a. Med Chem. 2006 Nov;2(6):565-8. doi: 10.2174/1573406410602060565. Med Chem. 2006. PMID: 17105437

4

Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.

Voigt B, Coburger C, Monár J, Hilgeroth A. Voigt B, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2007 Aug 1;15(15):5110-3. doi: 10.1016/j.bmc.2007.05.036. Epub 2007 May 18. Bioorg Med Chem. 2007. PMID: 17533131

5

Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.

Duarte N, Járdánházy A, Molnár J, Hilgeroth A, Ferreira MJ. Duarte N, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2008 Oct 15;16(20):9323-30. doi: 10.1016/j.bmc.2008.08.071. Epub 2008 Aug 31. Bioorg Med Chem. 2008. PMID: 18824363

6

Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.

Coburger C, Wollmann J, Krug M, Baumert C, Seifert M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2010 Jul 15;18(14):4983-90. doi: 10.1016/j.bmc.2010.06.004. Epub 2010 Jun 9. Bioorg Med Chem. 2010. PMID: 20598550

7

Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation.

Hilgeroth A, Baumert C, Coburger C, Seifert M, Krawczyk S, Hempel C, Neubauer F, Krug M, Molnár J, Lage H. Hilgeroth A, et al. Med Chem. 2013 Jun 1;9(4):487-93. doi: 10.2174/1573406411309040002. Med Chem. 2013. PMID: 23167942

8

Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 Inhibitors.

Hilgeroth A, Hemmer M, Neuber S, Molnár J, Lage H. Hilgeroth A, et al. Med Chem. 2015;11(4):329-35. doi: 10.2174/1573406410666141111100720. Med Chem. 2015. PMID: 25391533

9

Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies.

Hemmer M, Krawczyk S, Simon I, Hilgeroth A. Hemmer M, et al. Among authors: hilgeroth a. Bioorg Med Chem Lett. 2015 Aug 1;25(15):3005-8. doi: 10.1016/j.bmcl.2015.05.018. Epub 2015 May 22. Bioorg Med Chem Lett. 2015. PMID: 26048803

10

Discovery of substituted 1,4-dihydroquinolines as novel class of ABCB1 modulators.

Hemmer M, Krawczyk S, Simon I, Lage H, Hilgeroth A. Hemmer M, et al. Among authors: hilgeroth a. Bioorg Med Chem. 2015 Aug 1;23(15):5015-5021. doi: 10.1016/j.bmc.2015.05.016. Epub 2015 May 15. Bioorg Med Chem. 2015. PMID: 26059595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters